Characteristic | Number |
---|---|
Age, mean ± SD, years (range) | 67.4 ± 8.22 (51–85) |
Sex (%) | |
Female | 52 (76.5) |
Male | 16 (23.5) |
Tumor location of the thoracic (%) | |
Upper | 7 (10.3) |
Middle | 49 (72.1) |
Lower | 12 (17.6) |
Tumor histopathology (%) | |
Squamous cell carcinoma | 66 (97) |
Other | 2 (3) |
Tumor grading (%) | |
Well differentiated | 21 (30.8) |
Moderately differentiated | 34 (50) |
Poorly differentiated | 13 (19.1) |
Systemic therapy group (n = 19) | |
cT stage (%) | |
T2 | 1 (5.2) |
T3 | 10 (52.6) |
T4 | 8 (42.1) |
cN stage (%) | |
N0 | 3 (15.8) |
N1 | 4 (21.1) |
N2 | 12 (63.1) |
Radical surgery group (n = 49) | |
pT stage (%) | |
T1 | 8 (16.3) |
T2 | 9 (18.4) |
T3 | 29 (59.2) |
T4 | 3 (6.1) |
pN stage (%) | |
N0 | 28 (57.1) |
N1 | 13 (26.5) |
N2 | 6 (12.2) |
N3 | 2 (4.1) |